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ABSTRACT
Objective: Amiodarone used as an antiarrhythmic agent bears a structural resemblance to thyroid hormones containing about one-third iodine by 
weight. The pro-oxidant potentialities of amiodarone induced changes were studied.
Materials and Methods: Male adult Wister rats were divided into two groups of eight animals each, and amiodarone was supplemented orally 
for 30 days against control. The urinary iodine content of both the groups was measured. Animals were sacrificed after completion of treatment; 
investigated parameters were adrenal morphology and histology, adrenal ∆5 3β hydroxy steroid dehydrogenase (HSD) and serum cortisol level. 
Superoxide dismutase (SOD), catalase and lipid peroxidation (LPO) level were assayed in the liver, kidney and testis along with their histology. Serum 
glutamic-oxaloacetic transaminase (SGOT) and glutamic-pyruvate transaminase (SGPT) were measured. Obtained results were interpreted against 
the control group of rats.
Results: Urinary iodine level was high after the amiodarone exposure. Hypertrophied cortex with enhanced ∆5 3β HSD activity in adrenal caused 
elevated serum cortisol level. Amiodarone exposure had increased LPO level with a concomitant rise in catalase and SOD activities in liver, kidney and 
testis in comparison to control (p<0.001). Simultaneously kidney showed shrinkage of the glomerulus, in liver the area surrounding the central canal 
found disrupted and in the testis seminiferous tubules, and germ cells were disorganized in comparison to control. SGOT and SGPT level were found 
elevated in the treated group.
Conclusion: Amiodarone exposure develops stress for the metabolism and deiodinization of amiodarone releasing excessive iodine in circulation 
that in turn generates reactive oxygen species and free radicals resulting cellular damage of stress vulnerable organs.
Keywords: Amiodarone, Excess iodine, Hypertrophied adrenal, Cellular damage, Stress-vulnerable organs, Reactive oxygen species.
INTRODUCTION
Amiodarone is a benzofuran derivative containing a phenol moiety with 
two atoms of covalently bound iodine having structural resemblance to 
thyroid hormones [1]. It is amphiphilic with both hydrophobic portions 
presented by tertiary amine, for this reason it is highly lipophilic drug. 
The drug is highly soluble in chloroform and methanol but poorly 
soluble in water [2]. It is used worldwide for treatment of cardiac 
dysfunction such as arrhythmia. In spite of its therapeutic effect, it has 
multi organ side effects [3]. The commercial availability of amiodarone 
is in tablet as well as an intravenous formulation. Amiodarone has been 
reported as an enhancing agent in free radicals generation and also 
in mitochondrial hydrogen peroxide production [4]. It has relatively 
high iodine content; about 37% of its molecular mass is occupied by 
iodine [5]. Chronic treatment is associated with 40-fold increases in 
plasma and urinary iodide levels [1]. Each molecule of amiodarone 
contains two iodine atoms. It is estimated that amiodarone metabolism 
in liver releases approximately 3 mg of inorganic iodine to the systemic 
circulation per 100 mg of amiodarone [6]. The average iodine content 
in human male diet is about 0.15 mg/day [7]. Thus, a daily dose of 
100 mg amiodarone intake can certainly increase iodine load in the 
physiological system.
Reactive oxygen species (ROS) are chemically reactive molecules 
containing oxygen. ROS form as a natural by-product of the normal 
metabolism of oxygen and have important roles in cell signaling and 
homeostasis. Examples include oxygen ions and peroxides. Cumulative 
effects of ROS may result in significant damage to cell structures and 
have been implicated as an underlying agent in various pathological 
conditions [8]. ROS are also generated by exogenous sources such 
as ionizing radiation [9]. There are also reports on excessive iodine 
induced ROS mediated oxidative stress [1,10].
During oxidative stress, the oxidation exceeds the antioxidant symptoms 
in the body secondary to a loss of the balance between them [11]. It 
causes hazardous events such as lipid peroxidation (LPO), oxidative 
DNA damage etc. To ameliorate this cellular oxidative stress human/
animal body has an intricate antioxidant defense mechanism facilitated 
by superoxide dismutase (SOD), catalase and glutathione – enzymes 
that are important in the elimination of free radicals and are considered 
to play a significant role in quenching ROS and thereby display a 
modulatory role in different diseased condition [8].
Information on amiodarone that bears a structural resemblance to 
thyroid hormones containing 39% iodine by weight induced generation 
of ROS and associated disorders in stress vulnerable organs are scanty. 
The current study thus examines the effects of the amiodarone exposure 
on the development of oxidative stress if any in stress vulnerable organs 
as adrenal, kidney, liver, and testis.
MATERIALS AND METHODS
Reagents
Thiobarbituric acid (TBA), trichloroacetic acid (TCA), HCL, chloroform 
was purchased from Sisco Research Laboratories (SRL), Mumbai, India; 
bovine serum albumin (BSA), ethylenediaminetetraacetic acid (EDTA), 
MnCl2, isooctane, cortisol were purchased from Sigma Chemical Company, 
Steinheim, Germany; Ethanol, ß-estradiol and triton X-100 used in the 
study are of analytical grade and were was purchased from LOBA Chemie 
Pvt. Ltd, Mumbai, Maharashtra, India; nicotinamide adenine dinucleotide 
phosphate (NADPH), EDTA-MnCl2, Marcaptoethanol from Alfa Aesar.
Maintenance of animals
3-month-old adult male albino rats of the Wistar strain weighing 110 
± 10 g were used. The animals were maintained according to national 
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guidelines and protocols, and the study was approved by the Institutional 
Animal Ethics Committee. The animals were housed in hygienic 
polypropylene cages as well as maintained in a controlled environment 
at temperature 22°C ± 2°C and relative humidity (40-60%) in an animal 
house with a constant 12 hrs light/12 hrs dark schedule. The animals 
were fed a standardized diet, which consisted of 70% wheat, 20% 
Bengal gram, 5% fish meal powder, 4% dry yeast powder, 0.75% refined 
sesame oil, 0.25% shark liver oil, and water ad libitum [12]. The rats were 
divided into two groups of eight animals each: The experimental group 
were orally administered amiodarone for 30 days and was paired with a 
control group. Control rats were fed on a normal laboratory standardized 
diet whereas experimental rats received amiodarone. Feed consumption, 
corrected for wasted feed was noted regularly whereas body weights 
were measured after every seven days. During the last week of the 
treatment, animals in both groups were kept in metabolic cages for 24 
hrs to collect urine over xylene for the analysis of iodine.
All the animals were sacrificed 24 hrs after the last feeding (i.e., during 
9-10 am on the day of the experiment to avoid any discrepancy that 
may arise for diurnal variation) following standard protocols and 
ethical procedures. Blood samples were collected, and serum was kept 
separated for hormone assay.
Dose of amiodarone
Amiodarone at the dose of 0.17 mg/kg body weight/day [13]was given 
orally for 30 days, dissolving in 5% dextrose solution because of its 
solubility in organic solvents (Amiodarone was collected in the 100 mg 
and 200 mg ampoule, from registered medical stores). The control 
group was provided with the same quantity of water.
Organ weight
Just after sacrifice kidney, adrenal and testis were dissected out and 
weighed. The relative weight of organs (g/mg) was expressed per 100 g 
body weight.
Histological studies
The adrenal gland, testis, kidney and liver after dissection were fixed in 
bouins fluid for 24 hrs. These were processed and embedded in paraffin 
wax. 5 μ thick sections were obtained on cutting in microtome. These 
sections were then stained by hematoxylene and eosin and examined 
under light microscope.
Measurement of LPO (in the liver, kidney and testis)
Tissue was taken in 1 mL of phosphate buffer and was homogenized 
at 4°C. Following homogenization, 1 mL homogenate was mixed 
thoroughly with TBA-TCA-HCL mixture. The solution was heated for 
10 minutes. After cooling the precipitate was removed by centrifugation 
at 5000 rpm for 30 minutes. The absorbance of the sample was 
determined at 435 nm against a blank that contained all the reagents 
minus the tissue homogenate following the method of Ohkawa et al. [14].
Measurement of catalase activity (in the liver, kidney and testis)
Tissue was quickly removed and washed in ice cold normal saline, dried 
on filter paper. Homogenization was carried out at 4°C in ice cold 0.2 M 
sucrose solution. The crude homogenate was centrifuged at 3000 rpm 
for 20 minutes at 4°C. The pallet was discarded, and the supernatant was 
further centrifuged at 8000 rpm for 30 minutes. The post mitochondrial 
supernatant thus obtained was utilized for the catalase measurement 
after the method of Aebi, [15].
Measurement of SOD activity (in the liver, kidney and testis)
Tissue was taken in phosphate buffer and was homogenized. The crude 
homogenate was centrifuged at 2500 rpm for 30 minutes. Then in the 
cuvette the following solutions were subsequently added - 1 ml TDA, 
60 μl NADPH, 40 μl EDTA-MnCl2 and 0.5 mL sample. In the control, the 
sample was replaced by equal volume of the medium used for enzyme 
solution. The absorbance was taken at 640 nm over a 5 minutes period. 
Marcaptoethanol was added later, and the decrease in absorbance was 
noted for about 10 minutes following the method of Marklund and 
Marklund [16].
Measurement of adrenal ∆5 3β- hydroxyl steroid dehydrogenase 
(HSD) activity
The tissue was homogenized with homogenizing fluid containing 
20% spectroscopic grade glycerol, 5 mM potassium phosphate and 
1 mM EDTA at a tissue concentration of 100 mg/mL homogenizing 
mixture and centrifuged at 10,000 rpm at a constant temperature of 
4°C. The supernatant was used for the assay purpose. The activity 
was determined by optical measurement of the rate of reduction 
of NAD. The reaction system contain in a final volume of 3.0 mL. 
100 μM of sodium pyrophosphate, 0.5 Μm of NAD, 30 μg of substrate 
of 3β each in 0.02 mL of purified doxin and a suitable quantity of 
enzyme (200-500 μl) to initiate the reaction at final pH of 9.1. The 
reactions were carried out in the silica cuvettes of 1.0 cm light path, 
in a spectrophotometer at 340 mμ absorbance. The activities were 
measured at 15 seconds interval against a blank containing all 
components except the steroid. One unit of enzyme activity is the 
amount causing change in absorbance of 0.001/min when enzyme 
serves as substrate [17].
Fluorometric determination of serum cortisol [18]
Standard cortisol solution was prepared by dissolving 1 mg cortisol 
in 2.5 ml ethanol and volume was made up to 25 mL by distilled 
water. In 10 mL glass stopper extraction tube 0.5 mL serum was 
taken. For blank 0.5 mL distilled water and for standard 0.4 μg and 
0.08 μg cortisol/0.5 mL distilled water were taken respectively in 
separate extraction tube. In each tube 1.5 mL isooctane was added, 
mixed thoroughly and was centrifuged for separating the layers. The 
top isooctane layer was discarded by aspiration. Then to each tube 
3 mL chloroform was added and mixed thoroughly on a vortex for 
extraction and centrifugation. The top aqueous layer was discarded 
by aspiration. Then 0.25 mL of 0.1 N sodium hydroxide was added to 
each tube, mixed well and centrifuged. The top layer was discarded by 
aspiration. 2.5 mL of chloroform was taken in a separate set of 5 mL 
glass stopper tube containing 3 mL of acid alcohol mixture was mixed 
and centrifuged. Then 2.5 mL of bottom layer from each tube was 
taken in the cuvette and was kept for 45 minutes. The fluorescence 
was measured with the spectrofluorometer at 462 μm (excitation) 
and 518 μm (emission) wave length by setting the fluorometer at an 
arbitrary point of 80 with high standard (0.08 μg). The concentration 
of cortisol (μg/dl) was calculated by multiplying the conc. of standard 
with sample.
Estimation of urinary iodine level
Urine sample was digested followed by subsequent ashing, and iodine 
was measured by its catalytic action on the reduction of ceric ion (Ce++) 
to cerous ion (Ce3+)[19], maintaining internal quality control.
Protein estimation
Proteins were estimated by the method of Lowry et al. [20] using BSA 
as the standard protein.
Statistical analysis
Results were expressed as mean ± standard deviation. Differences 
between-group was established using t-test. A value of p<0.001 
was interpreted as statistically significant. Statistical analyses were 
performed using Origin 89 (Northampton, MA, USA) and MS-Office 
Excel 2007 software packages.
RESULTS
Body weight
The body weight of the control animals increased progressively 
throughout the period of investigation, with a net body weight gain 
of +44.178% (Table 1). However, the net body weight gain of the 
animals fed with amiodarone was only +16.78% at the end of the total 
experimental period.
Food intake and water consumption
Total food consumption by weight was similar in all the groups of 
experimental and control animals. Average food consumption of the 
Asian J Pharm Clin Res, Vol 7, Issue 4, 2014,177-183
 Chakraborty et al. 
179
control rats was 14.08 ± 0.83 g/day and that of the rats administered 
with amiodarone was 13.55 ± 0.76 g/day; similarly when the water 
intake pattern was recorded, the average intake in control group was 
10.15 ± 0.63 mL/day/rat whereas amiodarone treated group was 9.67 
± 0.57 ml/day/rat respectively (Table 2).
Adrenal, testis and kidney weight
The weight of adrenal glands was significantly increased (p<0.001) 
after amiodarone administration as compared to their respective 
control group (Table 3) while the relative testicular and kidney weight 
were significantly reduced in the experimental groups (p<0.001).
Serum glutamic-pyruvate transaminase (SGPT) and serum 
glutamic-oxaloacetic transaminase (SGOT) activities
SGPT and SGOT activities were increased significantly (p<0.001) when 
compared to amiodarone treated group after the exposure (Table 4).
LPO level in liver, kidney and testis
LPO level was significantly increased (p<0.001) in the liver, kidney 
and testis of amiodarone-treated rats as compared to their respective 
control (Table 5).
Antioxidant enzyme activities
Figs. 1 and 2 demonstrates antioxidant enzyme activities viz. SOD and 
catalase in liver, kidney and testis of control and amiodarone treated 
experimental animals. Amiodarone administration caused a statistically 
significant (p<0.001) stimulation in the activity of those enzymes over 
the respective control values.
Adrenal 3β HSD activity
Adrenal 3β HSD was significantly (p<0.001) increased in the 
amiodarone exposed groups compared to controls (Fig. 3).
Urinary iodine excretion pattern
The urinary iodine content of amiodarone treated group was 41.25 ± 
2.21 μg/dl and in the control group was 32.03 ± 1.78 μg/dl and was 
significantly (p<0.001) increased compared to control (Fig. 3).
Histopathological studies of liver, kidney, testis and adrenal
Histological assessments performed on studied organs from the 
different groups are presented in Plate 1. Adrenal cell mass showed a 
hypertrophied cortex upon comparison to control. The seminiferous 
tubules and germ cells in the testis were disorganized whereas in 
kidney shrinkage of glomerulus and in the liver the area surrounding 
the central canal was disrupted in the treated groups as compared to 
control groups.
DISCUSSION
Amiodarone, a structural analogue of thyroid hormone, is a well-
known anti-arrhythmic agent used in the treatment of various 
kinds of life threatening cardiac arrhythmias and ultimately in the 
prevention of death caused due to cardiac arrest [21]. Long term use of 
amiodarone can induce adverse effects on various organ systems such 
as kidney, liver, testis, skin, adrenal, thyroid, alveolar tissue and even 
in myocardial tissue [22]. However, effects of amiodarone as cellular/
molecular stressor are less highlighted in the available literature. In this 
investigation, attempt was made to study the effect of the amiodarone 
exposure on some stress vulnerable organs such as adrenal, liver, testis 
and kidney by evaluating certain invasive and non-invasive parameters 
after its exposure.
The body weight gain percentage was significantly decreased in 
amiodarone treated rats as compared to the control group . Similar 
observations were also reported in other studies [23]. The accumulation 
of amiodarone occurs mostly in adipose tissue [24] because of its lipid 
solubility. The underlying pathophysiology of this observation is due 
to excess iodine as incorporated in the amiodarone molecule (37.5% 
of organic iodine by molecular weight), which may cause thyroid 
dysfunction manifesting by hypothyroidism or hyperthyroidism and 
are characterized clinically by decreased growth and weight loss 
respectively. In hypothyroid condition, both syntheses of proteins and 
growth rate is retarded; as in the later, a large amount of the energy 
produced is dissipated as heat, with less in the form of the required 
energy-rich phosphate compound hence resulting in weight loss 
despite a normal appetite [25]. However, the food intake and water 
consumption showed no significant difference in amiodarone exposed 
rats when compared to their respective control groups.









gain in body 
weight (g%)
Control 112.86±4.1 162.72±5.4 44.178
Amiodarone treated 116.25±5.5 135.67±6.2 16.785*
Values are mean±SD of 8 rats. When the comparison between the two was 
done following t-test, a significant difference between the two groups was 
found (p<0.001) denoted by asterisk. SD: Standard deviation
Table 2: Amiodarone induced alteration in food intake and 
water consumption





Amiodarone treated 13.55±0.76 9.67±0.57
Values are mean±SD of 8 rats. When the comparison between the two was done 
following t-test, no significant difference between the two groups was found. 
SD: Standard deviation
Table 3: Amiodarone induced alteration in relative weight of the 
adrenal gland, testis, kidney






Control 11.728±0.73 1.504±0.094 0.638±0.03
Amiodarone treated 14.788±0.92* 1.38±0.086* 0.594±0.02*
Values are mean±SD of 8 rats. When the comparison between the two was 
done following t-test, a significant difference between the two groups was 
found (p<0.001) denoted by asterisk. SD: Standard deviation
Table 4: Amiodarone induced alteration in SGPT and SGOT 
activities
Group SGPT activity IU/l SGOT activity IU/l
Control 1.31±0.13 1.51±0.75
Amiodarone treated 1.94±0.51* 1.87±0.98*
Values are mean±SD of 8 rats. When the comparison between the two 
was done following t-test, a significant difference between the two groups 
was found (p<0.001) denoted by asterisk. SGPT: Serum glutamic-pyruvic 
transaminase, SGOT: Serum glutamic oxaloacetic transaminase, SD: Standard 
deviation
Table 5: Amiodarone induced alteration in LPO in liver, kidney 
and testis
Group (nmole TBARS/mg protein)
LPO in liver LPO in kidney LPO in testis
Control 9.05±1.74 8.78±1.86 4.1±0.61
Amiodarone treated 14.95±1.88* 13.72±2.25* 13.3±1.12*
Values are mean±SD of 8 rats. When the comparison between the two was 
done following t-test, a significant difference between the two groups was 
found (p<0.001) denoted by asterisk. LPO: Lipid peroxidation, SD: Standard 
deviation, TBRAS: Thiobarbituric acid reactive substances
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The weight of the adrenal gland was found to be increased in 
amiodarone treated group of rats in comparison to the control 
group. The increase in adrenal weight may be for the development 
of stress induced by excess iodine in amiodarone resulting in the 
release of more glucocorticoids through hypothalamo-pituitary-
adrenal axis [26]. Similar observations were also found in studies on 
calves feeding excess iodine [27]. Amiodarone has been reported to 
induce pheochromocytoma, an adrenal gland tumor [28]. However 
the weight of kidney was decreased in rats treated with amiodarone, 
which may be for the increase in urinary N-acetyl-glucosamine 
and alkaline phosphatase excretion that corresponds with tubular 
alterations resulting in weight reduction and was confirmed by electron 
microscopy [29]; testis weight was also concomitantly decreased that 
corresponds to the studies of Dobs et al. [30] who reported atrophic 
Fig. 3: Changes in amiodarone-induced alteration in adrenal 3 β hydroxy steroid dehydrogenase activity and urinary iodine content in 
experimental groups compared to control groups. Values are mean ± standard deviation of 8 rats. When the comparison between the two 
was done following t-test, a significant difference between the two groups was found (p<0.001)
Fig. 1: Changes in amiodarone-induced alterations in superoxide dismutase in different organs. Values are mean ± standard deviation of 8 
rats. When the comparison between the two was done following t-test, a significant difference between the two groups was found (p<0.001)
Fig. 2: Changes in amiodarone induced alterations in catalase in different organs. Values are mean ± standard deviation of 8 rats. When 
the comparison between the two was done following t-test, a significant difference between the two groups was found (p<0.001)
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testes commonly observed in amiodarone-treated men possibly for the 
reduction of spermatogenesis, which ultimately results in a decrease in 
testis weight since it is very vulnerable to oxidative stress [31].
Adrenal ∆5 3β HSD is a regulatory enzyme that converts 17 hydroxy 
pregnenolone to 17 hydroxy progesterone, which leads to the 
production of cortisol in the steroidogenic pathway [32]. ∆5 3β HSD was 
measured in adrenal gland and found that its activity was increased 
in treated group as compared to control group, suggesting that the 
this ∆5 pathway is stimulated under the influence of amiodarone, 
which is in line with the earlier findings that during stress the weight 
of this endocrine gland is increased and adrenal ∆5 3β HSD activity is 
elevated [33]. In this study, the cortisol level was found to be increased, 
and it is the reflection of higher activity of rate limiting enzyme though 
the stimulation of hypothalamic pituitary adrenal axis. It might be 
for the free radicals that are produced during the metabolism of 
amiodarone liberating excess iodine. It has been previously reported 
that amiodarone, containing excess iodine generates free radicals in 
vitro and caused a significant increase of NADPH and Fe3+ induced LPO 
in the liver microsomal fraction [34].
LPO in liver, kidney and testis were increased significantly in amiodarone 
treated animals measured by tissue thiobarbituric acid reactive 
substances production as compared to the respective control group. As 
widely known, LPO refers to oxidative degradation of lipids. It is a process 
in which free radicals steal electrons from the lipid in the cell membrane. 
LPO is one of the adverse effects of amiodarone therapy that occurs due 
to free radical mediated chain oxidation [35]. Malonaldehyde (MDA) 
levels thus formed indicate the intoxication and generation of oxidative 
stress in those organs. Excess iodine has been proved to generate stress 
in adrenal [26] and also in some target tissues of thyroid hormone such 
as hepatocytes [36]. The amiodarone when deiodinized after metabolism 
releases excess iodine in circulation, that might generate free radicals and 
those in the liver, kidney and testis can enhance the rate of LPO evidenced 
by high MDA levels. In our present study, MDA levels in liver, kidney and 
testis increased significantly in comparison to control.
The ROS that are generated as a result of metabolism of amiodarone 
are counteracted by antioxidant defense systems e.g. glutathione 
peroxidase, SOD, catalase etc. present in the physiological system. 
Amiodarone treated animals showed a higher level of SOD activity; 
SOD catalyses the dismutation of superoxide [O2−] ions into oxygen and 
hydrogen peroxide. They are important antioxidant marker in nearly all 
cells exposed to oxygen and destroy the highly reactive oxygen radical 
by converting it into less reactive hydrogen peroxide [37]. As proposed 
earlier [10], the free radicals production after administration of high 
dose of iodide could overshadow the normal cellular defense mechanism 
against those free radicals. Excess iodine has been reported to cause 
oxidative stress and changes in SOD activities. Hence, the amiodarone 
induced oxidative damage followed by free radical formation, which 
may concomitantly increase the SOD activity as observed in this study 
in order to neutralize those ROS in these organs.
On the other hand, catalase is the enzyme, which is present mainly in 
the peroxisomes of mammalian cells and increased catalase activity 
parallels to an increase in hydrogen peroxide. In our study, catalase 
activity of kidney, liver and testis was found to be significantly 
increased in amiodarone treated group as compared to control the 
group. Amiodarone has already been known to be highly lipophilic 
and is concentrated in many tissues and cells, including hepatocytes 
in the liver and thus iodide are subsequently released over a long 
period [38]. The cause of amiodarone-induced hepatotoxicity appears 
to be for the direct damage to lipid bilayers and disturbance of 
lysosomal and/or mitochondrial function suggesting mitochondrial 
injury and dysfunction [39] that has been reflected by high SGOT and 
SGPT activities compared to their controls. The kidneys are vulnerable 
to damage as a result of perfusion and the increased concentrations of 
excreted compounds that occur in renal peri-tubular cells as a result 
of amiodarone administration [40]. The elevated level of catalase in 
those organs is to protect the cell against oxidative stress induced by 
amiodarone. An increase in catalase activity has been suggested to 
reflect a high production of radicals such as H2O2 [40]. These results 
demonstrate that amiodarone accumulates in the kidneys of rats that in 
turn and release excess iodine causing marked alterations in the activity 
of this antioxidant enzymatic activity. Excess iodine released from 
amiodarone causes toxic effects in different organs [41] by generating 
rather producing free radicals due to its pro-oxidant nature that in-turn 
increases catalase activity as observed in this study.
Plate 1: Photomicrographs of paraffin-embedded H and E - stained sections (a) control liver, (b) treated liver; (c) control kidney, 
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Histoarchitectural alterations of adrenal gland, liver, kidney and testis 
were observed in treated groups as compared to control. In adrenal, 
cell mass and cell size increased associated with hypertrophied 
cortex; seminiferous tubules and germ cell layer were disorganized 
in testis; glomerulus were shrinked in the kidney cortex and in 
liver the area surrounding the central canal found disrupted in the 
amiodarone-induced groups possibly for the development of cellular 
oxidative stress after amiodarone exposure. Amiodarone has been 
suggested to cause ultra structural effects on the thyroid gland and 
cytokine production [41-43]. These findings are consistent with the 
observations of our study.
Urinary iodine concentration in amiodarone treated groups found 
significantly high as 37% of its total molecular weight contains iodine [5]. 
Amiodarone is metabolized releasing free iodine in circulation, which 
results in iodine overload, the causative factor for the cellular and 
biochemical alterations of the studied organs as found in this study. As 
90% of the body’s iodine is excreted through urine [44] and thus, the 
iodine excretion pattern in amiodarone exposed group was found high, 
this may also be due to its extremely long terminal half-life [1].
Therefore amiodarone not only develops stress in adrenal but also 
in other important organs as the liver, kidney and testis as evidenced 
by their cellular changes as well as their enhanced SOD, catalase 
activities and LPO levels with increased SGOT and SGPT activities. 
It may thus be concluded that chronic amiodarone exposure 
develops cellular oxidative stress in stress vulnerable organs for the 
metabolism and deiodinization of amiodarone releasing excessive 
iodine in circulation that in turn might form ROS and free radicals 
resulting cellular damage.
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